UNITEDHEALTH GROUP INC

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Total Revenue $184.8b
$201.2b +8.83%
$226.2b +12.47%
$242.2b +7.03%
$257.1b +6.19%
$287.6b +11.84%
$324.2b +12.71%
$371.6b +14.64%
$400.3b +7.71%
$447.6b +11.81%
$449.7b +0.48%
Revenue from Products and Services $50.6b $54.2b $59.0b $65.0b $76.7b $86.3b $91.4b
Cost of Revenue $24.4b
$24.1b -1.25%
$27.0b +11.97%
$28.1b +4.14%
$30.7b +9.35%
$31.0b +0.94%
$33.7b +8.60%
$38.8b +15.03%
$46.7b +20.44%
$50.7b +8.48%
$365.2b +620.88%
Cost of products sold $24.4b
$24.1b -1.25%
$27.0b +11.97%
$28.1b +4.14%
$30.7b +9.35%
$31.0b +0.94%
$33.7b +8.60%
$38.8b +15.03%
$46.7b +20.44%
$50.7b +8.48%
Gross Profit (Calculated) $160.4b
$177.0b +10.36%
$199.2b +12.54%
$214.0b +7.42%
$226.4b +5.77%
$256.6b +13.32%
$290.5b +13.21%
$332.9b +14.60%
$353.6b +6.23%
$396.9b +12.25%
Selling, General and Administrative Expense $28.4b $29.6b $34.1b $35.2b $41.7b $42.6b $47.8b $54.6b $53.0b $59.6b
Amortization of Intangible Assets $882.0m $896.0m $898.0m $1.0b $1.1b $1.2b $1.3b $1.6b $1.7b $1.7b
Restructuring Costs $2.5b
Operating costs $28.4b $29.6b $34.1b $35.2b $41.7b $42.6b $47.8b $54.6b $53.0b $59.6b
Total operating costs $171.9b $185.9b $208.9b $222.5b $234.7b $263.6b $295.7b $339.3b $368.0b $428.6b
Earnings from operations $12.9b $15.2b $17.3b $19.7b $22.4b $24.0b $28.4b $32.4b $32.3b $19.0b
Operating Income (Loss) $12.9b
$15.2b +17.63%
$17.3b +14.04%
$19.7b +13.50%
$22.4b +13.82%
$24.0b +6.99%
$28.4b +18.63%
$32.4b +13.80%
$32.3b -0.22%
$19.0b -41.26%
$18.8b -0.68%
Interest Expense $1.1b $1.2b $1.4b $1.7b $1.7b $1.7b $2.1b $3.2b $3.9b $4.0b $4.0b
Investment and other income $828.0m $1.0b $1.4b $1.9b $1.5b $2.3b $2.0b $4.1b $5.2b $3.9b
Income (Loss) from Continuing Operations before Income Taxes, Domestic $28.3b $14.9b $14.6b
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $18.0b $20.7b $22.3b $26.3b $29.1b $20.1b $14.7b $14.6b
Current Income Tax Expense (Benefit) $4.7b $4.2b $3.5b $3.5b $5.0b $4.4b $6.4b $6.2b $5.1b $3.6b $1.7b
Provision for income taxes ($4.8b) ($3.2b) ($3.6b) ($3.7b) ($5.0b) ($4.6b) ($5.7b) ($6.0b) ($4.8b) ($1.9b)
Net earnings $7.1b
$10.8b +53.02%
$12.4b +14.40%
$14.2b +15.00%
$15.8b +10.75%
$17.7b +12.45%
$20.6b +16.39%
$23.1b +12.14%
$15.2b -34.14%
$12.8b -15.98%
$12.0b -5.96%
Net earnings attributable to UnitedHealth Group common shareholders $7.0b $10.6b $12.0b $13.8b $15.4b $17.3b $20.1b $22.4b $14.4b $12.1b
Net Income (Loss) Attributable to Parent $7.0b
$10.6b +50.46%
$12.0b +13.53%
$13.8b +15.46%
$15.4b +11.30%
$17.3b +12.22%
$20.1b +16.40%
$22.4b +11.24%
$14.4b -35.64%
$12.1b -16.31%
$12.0b -0.10%
Net Income (Loss) Attributable to Noncontrolling Interest $56.0m $265.0m $396.0m $400.0m $366.0m $447.0m $519.0m $763.0m $837.0m $751.0m $12.0b
Earnings Per Share, Basic $7.37 $10.95 $12.45 $14.55 $16.23 $18.33 $21.47 $24.12 $15.64 $13.28 $13.30
Earnings Per Share, Diluted $7.25 $10.72 $12.19 $14.33 $16.03 $18.08 $21.18 $23.86 $15.51 $13.23 $13.28
Common Stock, Dividends, Per Share, Declared $2.38 $2.88
Basic weighted-average number of common shares outstanding 952.0m 964.0m 963.0m 951.0m 949.0m 943.0m 937.0m 928.0m 921.0m 908.0m
Diluted weighted-average number of common shares outstanding 968.0m 985.0m 983.0m 966.0m 961.0m 956.0m 950.0m 938.0m 929.0m 911.0m
Weighted Average Number of Shares Outstanding, Basic 952.0m 964.0m 963.0m 951.0m 949.0m 943.0m 937.0m 928.0m 921.0m 908.0m 907.0m
Weighted Average Number of Shares Outstanding, Diluted 968.0m 985.0m 983.0m 966.0m 961.0m 956.0m 950.0m 938.0m 929.0m 911.0m 909.0m
Expenses
Capitalized Computer Software, Amortization $475.0m $550.0m $606.0m $721.0m $814.0m $923.0m $1.0b $1.2b $1.4b $1.7b
Costs and Expenses $171.9b $185.9b $208.9b $222.5b $234.7b $263.6b $295.7b $339.3b $368.0b $428.6b
Depreciation and amortization $2.1b $2.2b $2.4b $2.7b $2.9b $3.1b $3.4b $4.0b $4.1b $4.4b $4.3b
Dilutive effect of common share equivalents $16.0m $21.0m $20.0m $15.0m $12.0m $13.0m $13.0m $10.0m $8.0m $3.0m
Earnings attributable to noncontrolling interests ($56.0m) ($265.0m) ($396.0m) ($400.0m) ($366.0m) ($447.0m) ($519.0m) ($763.0m) ($837.0m) ($751.0m)
Goodwill, Impairment Loss $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims $117.0b $130.0b $145.4b $156.4b $159.4b $186.9b $210.8b $241.9b $264.2b $314.0b
Loss on sale of subsidiary and subsidiaries held for sale $0 $0 ($8.3b) ($265.0m)
Medical costs $117.0b $130.0b $145.4b $156.4b $159.4b $186.9b $210.8b $241.9b $264.2b $314.0b
Premiums $144.1b $158.5b $178.1b $189.7b $201.5b $226.2b $257.2b $290.8b $308.8b $352.2b
Policyholder Benefits and Claims Incurred, Net $264.2b $314.0b

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.